| Q90292811 | A Reappraisal of Thymosin Alpha1 in Cancer Therapy |
| Q40787763 | A subpopulation of T cells detected by AET-treated sheep erythrocytes |
| Q39802098 | Adult thymectomy prevention of the appearance of suppressor T cells which depress contact sensitivity to picryl chloride and reversal of adult thymectomy effect by thymus extract |
| Q38533845 | Advances in the basic and clinical applications of thymosin β4. |
| Q72829896 | Autoimmune hemolytic anemia as a manifestation of T-suppressor-cell deficiency |
| Q40734667 | Cellular and humoral requirements for T-cell development |
| Q67287818 | Characterization of facteur thymique sérique (FTS) in the thymus. II. Direct demonstration of the presence of FTS in thymosin fraction V |
| Q41166424 | Clinical trials with thymosin |
| Q41048097 | Comparative study of the effect of thymosin and supernatant from epithelial thymic cells on antibody production (author's transl) |
| Q24634732 | Complete amino acid sequence of bovine thymosin beta 4: a thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populations |
| Q39852671 | Current status of thymosin research: evidence for the existence of a family of thymic factors that control T-cell maturation |
| Q40300955 | Cyclic nucleotide changes in murine lymphocytes following thymosin incubation in vitro |
| Q42002571 | Effect of synthetic thymic humoral factor (THF-gamma 2) on T cell activities in immunodeficient ageing mice |
| Q40146354 | Effect of thymosin and lipopolysaccharide on murine lymphocyte cyclic AMP |
| Q41227836 | Effect of thymosin in vitro on T cell levels during radiation therapy.Correlations with radiation portal and initial T cell levels |
| Q66973539 | Effect of thymosin on lymphoid cells from human fetal organs |
| Q67249807 | Effect of various thymic and nonthymic factors on in vitro antibody formation by spleen cells from nude mice |
| Q39855200 | Endogenous Thymic Factors Regulating Cell Proliferation and Analysis of Their Mechanism of Action |
| Q36341697 | Enrichment of in vitro and in vivo immunologic activity of purified fractions of calf thymic hormone |
| Q40285196 | Evaluation of functional thymic hormones in Arabian horses with severe combined immunodeficiency |
| Q34079570 | Fifteen years of prothymosin alpha: contradictory past and new horizons |
| Q44255414 | Heterogeneity of stem cells in severe combined immunodeficiency |
| Q28307864 | History of the discovery of the thymosins |
| Q72625467 | Humoral factors in the regulation of cell proliferation in haematopoiesis. I. Granulopoiesis and lymphopoiesis (author's transl) |
| Q39773332 | Immune modulation and cancer control |
| Q69931600 | Immunohistochemical and electron microscopic changes in the endocrine pancreas after thymectomy |
| Q70830235 | Immunomodulating activity of thymosin fraction 5 and thymosin alpha 1 in immunosuppressed mice |
| Q72832586 | Immunomodulation and therapeutic characterization of thymosin fraction five |
| Q36300212 | Immunoregulation in senescence: increased inducibility of antigen-specific suppressor T cells and loss of cell sensitivity to immunosuppression in aging mice |
| Q67058121 | Immunotherapy of cancer with thymosin |
| Q72514772 | In vitro effects of prealbumin on T-cell-dependent immune responses of the mouse |
| Q44589300 | In vivo effect of prothymosin-alpha 1 on humoral and cell-mediated immune responses in the young rat |
| Q54436319 | Increased thymic hormone responsive suppressor T lymphocyte function in chronic active hepatitis |
| Q72935933 | Induction and augmentation of mitogen-induced immune interferon production in human peripheral blood lymphocytes by Nα-desacetylthymosin αl |
| Q36340021 | Induction in vivo and in vitro of terminal deoxynucleotidyl transferase by thymosin in bone marrow cells from athymic mice |
| Q40652709 | Induction of Suppressor T Cells in Systemic Lupus Erythematosus by Thymosin and Cultured Thymic Epithelium |
| Q35351404 | Induction of terminal deoxynucleotidyl transferase and Lyt antigens with thymosin: identification of multiple subsets of prothymocytes in mouse bone marrow and spleen |
| Q66883463 | Influenza: Response of T-Cell Lymphopenia to Thymosin |
| Q72088266 | Inhibition of lymphocyte production via thymic factors |
| Q37909411 | Intracellular and extracellular cytokine-like functions of prothymosin α: implications for the development of immunotherapies |
| Q43836840 | Is serum thymic factor of thymic origin? |
| Q71071225 | Isolation of thymosin alpha 1 from thymosin fraction 5 of different species by high-performance liquid chromatography |
| Q70526203 | Maturational effects of thymic hormones on human helper and suppressor T cells: effects of FTS ('Facteur Thymique Sérique') and thymosin |
| Q46704370 | Maturational impairment of thymic lymphocytes in streptozotocin-induced diabetes in rats |
| Q39838185 | Mitogenic response of marmoset lymphocytes: cytokinetics and identification of responsive cells |
| Q37395527 | Modulation of interleukin 2 receptor expression on normal human lymphocytes by thymic hormones |
| Q71070484 | Modulation of terminal deoxynucleotidyl transferase activity by thymosin |
| Q24628770 | Molecular cloning of cDNA for human prothymosin alpha |
| Q47194544 | On the molecular size of thymosins |
| Q67286331 | Partial reactivation of impaired immune competence in aged mice by synthetic thymus factors |
| Q40739023 | Presence of thymosin-like factors in human thymic epithelium conditioned medium |
| Q37673638 | Primary structure of rat thymus prothymosin alpha |
| Q43090553 | Production of thymosin alpha1 via non-enzymatic acetylation of the recombinant precursor |
| Q70430230 | Protective activity of thymosin against opportunistic infections in animal models |
| Q39567209 | Prothymosin Alpha and Immune Responses: Are We Close to Potential Clinical Applications? |
| Q44739055 | Prothymosin alpha and alpha 1-like peptides |
| Q37988329 | Prothymosin alpha: a ubiquitous polypeptide with potential use in cancer diagnosis and therapy |
| Q36248692 | Prothymosin alpha: isolation and properties of the major immunoreactive form of thymosin alpha 1 in rat thymus |
| Q68062975 | Rapid isolation of thymosin beta 4 from thymosin fraction 5 by preparative high-performance liquid chromatography |
| Q35037948 | Rationale for combined use of fetal liver and thymus for immunological reconstitution in patients with variants of severe combined immunodeficiency |
| Q34078323 | Restoration of T-cell responsiveness by thymosin: expression of anti-tuberculous immunity in mouse lungs |
| Q34388508 | Restoration of delayed hypersensitivity to sheep erythrocytes by thymosin treatment of T-cell-depleted mice |
| Q70763973 | Resynthesis of trypsinized sheep red blood cell receptors on human lymphocytes: Comparison of the effects of immunopotentiators of biological and synthetic origin in vitro |
| Q40209379 | Serum thymic factor in subacute sclerosing panencephalitis patients |
| Q39432796 | Some endocrine aspects of the thymus gland |
| Q40692939 | Suppression by thymosin of pokeweed mitogen-induced differentiation of human B cells |
| Q66890107 | Suppressor Cell Activity in a Male Infant with T- and B-Lymphocyte Dysfunction Treated with Thymosin |
| Q69741984 | Synthesis and apparent secretion of prothymosin alpha by different subpopulations of calf and rat thymocytes |
| Q39681141 | Synthesis of Thymosin ?1, a Polypeptide of the Thymus |
| Q39443298 | T-Lymphocyte Differentiation Antigens Shared by Humans and Rhesus Monkeys |
| Q40734718 | T-lymphocyte maturation: cell surface markers and immune function induced by T-lymphocyte cell-free products and thymosin polypeptides |
| Q34075736 | The Endocrine Role of the Thymus and Its Hormone, Thymosin, in the Regulation of the Growth and Maturation of Host Immunological Competence |
| Q36739321 | The Gordon Wilson lecture. The history of the development of thymosin: chemistry, biology and clinical applications |
| Q40788614 | The Influence of Thymosin on Affinity Binding in the E-Rosette Assay |
| Q66883761 | The Need for Transcription and Translation for Differentiation of Bone Marrow Cells by Thymic Factors in Man |
| Q40204323 | The chemistry and biology of thymosin. I. Isolation, characterization, and biological activities of thymosin alpha1 and polypeptide beta1 from calf thymus |
| Q44697745 | The circadian rhythm of thymosin therapy during acute reovirus type 3 infection of neonatal mice |
| Q43755223 | The effect of thymosin on human T-cells from cancer patients |
| Q39820846 | The effect of thymosin on patients with disseminated malignancies.A phase I study |
| Q40596654 | The endocrine thymus: potential role for thymosin in the treatment of autoimmune disease |
| Q72119844 | The finding and significance of spermidine and spermine in Fraction 5 |
| Q24628113 | The human prothymosin alpha gene is polymorphic and induced upon growth stimulation: evidence using a cloned cDNA |
| Q40145152 | The in vitro induction of differentiation of putative human stem cells by thymosin and agents that affect cyclic AMP |
| Q40217777 | The incredible shrinking chalone |
| Q72921217 | The serum thymic factor (FTS). Chemical and biological aspects |
| Q72817409 | The thymosins—preclinical and clinical studies with fraction V and alpha-i |
| Q38075084 | Thymic Hormones |
| Q35013904 | Thymic activity in severe combined immunodeficiency diseases |
| Q33990137 | Thymic control of proliferation of T cell precursors in bone marrow |
| Q39986606 | Thymic factor in human sera demonstrable by a cyclic AMP assay |
| Q39503231 | Thymic hormones--a clinical update |
| Q93675189 | Thymic hormones: an overview |
| Q39831882 | Thymic peptide hormones: basic properties and clinical applications in cancer |
| Q40838210 | Thymic-dependent anti-hapten response in congenitally athymic (nude) mice immunized with DNP-thymosin |
| Q38871798 | Thymosin alpha 1 suppresses proliferation and induces apoptosis in breast cancer cells through PTEN-mediated inhibition of PI3K/Akt/mTOR signaling pathway |
| Q37506962 | Thymosin alpha 11: a peptide related to thymosin alpha 1 isolated from calf thymosin fraction 5 |
| Q42941363 | Thymosin alpha 1: biological activities, applications and genetic engineering production |
| Q34674378 | Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide |
| Q93675197 | Thymosin beta 4-like peptides |
| Q36289110 | Thymosin beta 4: a ubiquitous peptide in rat and mouse tissues |
| Q54117433 | Thymosin fraction 5 and 5A. |
| Q40113822 | Thymosin fraction-5 possesses antiproliferative properties in HL-60 human promyelocytic leukemia cells: characterization of an active peptide |
| Q72764666 | Thymosin modulation of regulatory T cell function |
| Q34094633 | Thymosin restoration of cellular immunity to Blastomyces dermatitidis in T-cell-depleted mice |
| Q58694411 | Thymosin α1 suppresses migration and invasion of PD-L1 high-expressing non-small-cell lung cancer cells via inhibition of STAT3–MMP2 signaling |
| Q40689413 | Thymosin-induced suppression of proliferative response of human lymphocytes to mitogens |
| Q39755294 | Thymosins and anti-thymosins: properties and clinical applications. |
| Q35753541 | Thymosins: chemistry and biological properties in health and disease |
| Q67009784 | Thymus Hormones: Diverse Molecules Producing Similar Biological Actions |
| Q39769727 | Use of Thymosin in the Treatment of Primary Immunodeficiency Diseases and Cancer |